COMMUNIQUÉS West-GlobeNewswire

GUERBET : H1 2024 results.
25/09/2024
H1 2024 results Very dynamic business activity H1 revenue: €419.2m, up 11.8% at CER 1 A trajectory driven by all activities and geographical areas Solid increase in profitability The restated EBITDA margin 2 was 15.4%, [...]
PHAXIAM : RAPPORT FINANCIER SEMESTRIEL
25/09/2024
Rapport Financier Semestriel 30 Juin 2024 PHAXIAM Pièce jointe PHXM_RFS_2024
PHAXIAM Provides Business and Financial Update For the First Half of 2024
25/09/2024
Continuous commitment to create a global leader in phage therapies to treat severe and resistant bacterial infections Ambitious development strategy on track with clear objectives set for the Prosthetic Joint Infections [...]
PHAXIAM fait le point sur ses activités et publie ses résultats financiers du premier semestre 2024
25/09/2024
Engagement continu pour créer un leader mondial de la phagothérapie pour traiter des infections bactériennes sévères et résistantes Une stratégie de développement ambitieuse en ligne avec les objectifs fixés pour le [...]
BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.
25/09/2024
KUALA LUMPUR, Malaysia, Sept. 25, 2024 (GLOBE NEWSWIRE) -- MRNA Scientific Sdn. Bhd. ("MRNA"), a subsidiary of BioNexus Gene Lab Corp. (Nasdaq: BGLC, the “Company”), and Protech Builders Sdn. Bhd. ("Protech"), a leading [...]
Celldex Therapeutics Presents Landmark 52 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EADV 2024
25/09/2024
- 71% of patients (150 mg Q4W) achieved complete response at Week 52 - - Rapid, profound and durable improvement in UAS7 as early as Week 1 with a deepening of response over 52 weeks - - Robust improvement across [...]
Boehringer Ingelheim expands cancer research at its Vienna site
25/09/2024
Inauguration of Angelika Amon research building in Vienna Sustainable research building at a cost of EUR 60 million offers modern office and laboratory space Over the past five years, Boehringer’s capital investments [...]
LifeLabs to Honour National Day for Truth and Reconciliation with Educational Initiatives and Community Support
25/09/2024
Vancouver, B.C., Toronto, ON, Sept. 25, 2024 (GLOBE NEWSWIRE) -- On September 30, LifeLabs will pause operations to recognize National Day for Truth and Reconciliation and Orange Shirt Day. This day honours the lost [...]
Capsa Healthcare Unveils the New Tryten P-Series: Engineering a Path to Better Care
25/09/2024
COLUMBUS, Ohio, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Capsa Healthcare, a leader in purposefully designed integrated solutions, proudly announces the launch of the new Tryten P-Series tablet and monitor carts that are [...]
Spinogenix Announces Launch of a Phase 2 Clinical Trial Evaluating SPG302 for the Treatment of Schizophrenia
25/09/2024
Phase 2 trial is designed to evaluate the safety, efficacy, tolerability, and pharmacodynamics of SPG302 in adults with a primary diagnosis of schizophrenia LOS ANGELES, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Spinogenix, [...]
Dallas Business Journal Recognizes USOSM COO Alisa Ulrey for Leadership
25/09/2024
IRVING, Texas, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Dallas Business Journal has selected U.S. Oral Surgery Management (USOSM) Chief Operations Officer Alisa Ulrey as a 2024 C-Suite Leaders Awards program honoree. The C- [...]
Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study
25/09/2024
- Patients are preselected for CDKN2A and/or CDKN2B abnormalities - - Safety and efficacy data to be reported at an upcoming oncology medical conference - BERKELEY HEIGHTS, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- [...]
ClinicalTrials.EU platform rolled out across Europe
25/09/2024
LONDON, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The European Clinical Trials Information Network ( ClinicalTrials.EU ) has today announced its official rollout across the continent. The patient-centric platform aims to solve [...]
Koelis Announces New Compact 3D Probe to Improve Workflow and Reprocessing
25/09/2024
New 3D Ultrasound Probe maximizes auto reprocessing compatibility New probe adaptor improves needle guidance for targeted biopsy and treatment GRENOBLE, France and PRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- [...]
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
25/09/2024
Please see enclosed pdf. Attachment 25092024_trading_in_shares_N_P_Louis-Hansen_ApS
InBrain Pharma to Present Positive Results from Its DIVE-I Phase I/II Clinical Trial for Parkinson’s Disease at the Congress of Parkinson’s Disease and Movement Disorders from September 27 to October 1 in Philadelphia
25/09/2024
Lille, September 25, 2024 - InBrain Pharma, a biopharmaceutical company specialized in neurodegenerative diseases, will present the positive results of its Phase I/II DIVE-I clinical trial for Parkinson’s disease at the [...]
Sanner Group acquires Gilero to expand its global medical device offering
25/09/2024
Sanner Group acquires Gilero to expand its global medical device offering Acquisition drives Sanner Group’s mission to offer a suite of world leading development and manufacturing services for its customers across the [...]
SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout
25/09/2024
VANCOUVER, British Columbia, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“ Sirona ” or the “ Company ”) provides the following update: Dear Shareholders, We are [...]
GoLiver Therapeutics is the winner of the France 2030 “innovation in Biotherapies and Bioproduction” call for its GOCLINICALS project, dedicated to a novel stem cell-based liver therapy
25/09/2024
Press release GoLiver Therapeutics has been awarded €1.6m from France 2030 to progress its first biomedicine, developed from pluripotent stem cells, into the clinic for the treatment of severe liver failures. Nantes, [...]

Pages